Position in GILD
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,328,338
+$190,244 QoQ
Shares Held
10,514
+28.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#964
of 2,266 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MILESTONE ASSET MANAGEMENT, LLC holds $27,891,738 across 7 Drug Manufacturers - General names. GILD ranks #6 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
141,848 | $8,173,281 | |
| 2 | LLY |
ELI LILLY & Co
|
6,415 | $7,694,343 | |
| 3 | AMGN |
Amgen Inc
|
17,878 | $6,473,981 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,957 | $2,178,974 | |
| 5 | ABBV |
AbbVie Inc.
|
6,977 | $1,755,692 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
10,514 | $1,328,338 | |
| 7 | PFE |
Pfizer Inc
|
11,924 | $287,129 |
All Filings in GILD
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,328,338 | 10,514 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,138,094 | 8,166 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $5,961,480 | 48,570 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,111,442 | 19,022 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $2,172,940 | 19,599 | Shares | Other | 2025-08-05 | |
| 2025-03-31 | $6,761,432 | 60,343 | Shares | Other | 2025-04-09 | |
| 2024-12-31 | $2,057,726 | 22,277 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,237,813 | 14,764 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,521,563 | 22,177 | Shares | Other | 2024-07-19 | |
| 2024-03-31 | $898,118 | 12,261 | Shares | Sole | 2024-04-23 | |
| No filing history on record for this holder in this stock. | ||||||